Skip to main content
VulnerabilityPublished

CVE-2026-1030: IBM Common Licensing · Generation of Error Message Containing Sensitive Information

Affects IBM Common LicensingSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 4.3 Medium.

Data as of 2 Nov 2026, 22:58 UTC

CVSS 3.1 base score
4.3Medium
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.2% chance of exploitation in 30 days – higher than 22% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 18 Sep 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 2 Nov 2026.

What to do

Affected software

ProductAffectedFixed in
IBMCommon LicensingAffected
  • Agent 9.0 – ART 9.0.0.2
6 affected builds
Fixed in–

CPE configurations (2)

  • cpe:2.3:a:ibm:common_licensing:agent:*:*:*:*:*:*:*
  • cpe:2.3:a:ibm:common_licensing:art:*:*:*:*:*:*:*

AI-suggested

Until official fixes or guidance are available, monitor IBM's security advisories for updates. Avoid exposing error messages to untrusted users where possible.

Description

IBM Common Licensing versions 9.0, 9.0.0.1, 9.0.0.2, and ART 9.0 series generate error messages that disclose sensitive information about their environment, users, or associated data. This information exposure vulnerability is identified as CWE-209. The issue has a medium severity with a CVSS score of 4.3. No specific affected versions are detailed, and no patch or remediation information is provided.

References

Community reviews

Loading reviews…